MiMedx Group, Inc. (MDXG)
4.59
-0.05
(-1.08%)
USD |
NASDAQ |
Oct 02, 16:00
4.59
0.00 (0.00%)
After-Hours: 20:00
MiMedx Group Price : 4.59 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 4.69 | 4.69 | 4.485 | 4.59 | 1.370M |
| Oct 01, 2026 | 4.65 | 4.68 | 4.57 | 4.64 | 1.189M |
| Sep 30, 2026 | 4.70 | 4.70 | 4.565 | 4.66 | 1.029M |
| Sep 29, 2026 | 4.65 | 4.685 | 4.58 | 4.67 | 901198.0 |
| Sep 28, 2026 | 4.655 | 4.725 | 4.55 | 4.68 | 881299.0 |
| Sep 25, 2026 | 4.71 | 4.71 | 4.40 | 4.67 | 1.460M |
| Sep 24, 2026 | 4.81 | 4.82 | 4.66 | 4.71 | 1.022M |
| Sep 23, 2026 | 4.93 | 4.99 | 4.67 | 4.77 | 1.003M |
| Sep 22, 2026 | 4.81 | 4.94 | 4.78 | 4.93 | 1.032M |
| Sep 21, 2026 | 4.79 | 4.84 | 4.75 | 4.81 | 915909.0 |
| Sep 18, 2026 | 4.65 | 4.795 | 4.614 | 4.77 | 3.905M |
| Sep 17, 2026 | 4.78 | 4.79 | 4.66 | 4.69 | 935377.0 |
| Sep 16, 2026 | 4.72 | 4.765 | 4.675 | 4.73 | 1.095M |
| Sep 15, 2026 | 4.64 | 4.795 | 4.58 | 4.72 | 1.147M |
| Sep 14, 2026 | 4.60 | 4.665 | 4.54 | 4.64 | 888919.0 |
| Sep 11, 2026 | 4.64 | 4.71 | 4.51 | 4.57 | 995845.0 |
| Sep 10, 2026 | 4.65 | 4.69 | 4.50 | 4.60 | 1.622M |
| Sep 09, 2026 | 4.64 | 4.70 | 4.56 | 4.68 | 1.049M |
| Sep 08, 2026 | 4.57 | 4.73 | 4.43 | 4.67 | 1.065M |
| Sep 04, 2026 | 4.41 | 4.585 | 4.41 | 4.57 | 624972.0 |
| Sep 03, 2026 | 4.54 | 4.61 | 4.345 | 4.43 | 841628.0 |
| Sep 02, 2026 | 4.52 | 4.71 | 4.52 | 4.55 | 1.040M |
| Sep 01, 2026 | 4.53 | 4.61 | 4.485 | 4.52 | 762366.0 |
| Aug 31, 2026 | 4.49 | 4.57 | 4.395 | 4.54 | 1.063M |
| Aug 28, 2026 | 4.49 | 4.635 | 4.48 | 4.50 | 887017.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Agenus, Inc. | 8.36 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Amgen, Inc. | 403.04 |
| Anika Therapeutics, Inc. | 19.10 |
Price Related Metrics
| PE Ratio | 116.20 |
| PS Ratio | 1.926 |
| Price to Book Value | 3.097 |
| Price to Free Cash Flow | 16.16 |
| Earnings Yield | 0.86% |
| Market Cap | 668.88M |
| Operating PE Ratio | 78.16 |
| Normalized PE Ratio | 116.50 |